Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1991-04-10
1992-09-08
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A01N 4500, C07J17200
Patent
active
051458462
ABSTRACT:
Compounds of the formula ##STR1## wherein R is hydrogen or hydroxy, R.sub.5 is hydrogen, and A is ##STR2## with the proviso that when A is --C.tbd.C--, R.sub.5 may also be deuterium, are described.
The compounds of formula I are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the treatment of neoplastic diseases such as leukemia, and as agents for the treatment of sebaceous gland diseases such as acne or seborrheic dermatitis.
REFERENCES:
patent: 4391802 (1983-07-01), Suda et al.
patent: 4610978 (1986-09-01), Dikstein et al.
patent: 4719205 (1988-01-01), DeLuca et al.
patent: 4804502 (1989-02-01), Baggliolini et al.
patent: 4851400 (1989-07-01), De Luca
patent: 4898855 (1990-02-01), Baggiolini
patent: 4929609 (1990-05-01), Batcho et al.
Rigby et al., 1,25-Dihydroxyvitamin D.sub.3 Induces Granulocytic Differentiation and Myeloid Specific Antigens in the HL-60 Promyelocytic Leukemia Cell Line, Blood 62(5):153a, 1983.
Shuna et al., Biological Activity of 24,24-Difluoro-1a,25-Dihydroxyvitamin D.sub.3 and 1a,25-Dihydroxyvitamin D.sub.3 -26,23 Lactone in Inducing Differentiation of Human Myeloid Leukemic Cells, Arch. Biochm. Biophys. 220:90-94, 1983.
Abe et al., Differentiation of Mouse Myeloid Leukemia Cells Induced by 1a,25-Dihydroxyvitamin D.sub.3 ; Proc. Natl. Acad. Sci: U.S.A. 78:4990-4994, 1981.
McCarthy et al., 1a,25-Dihydroxyvitamin D.sub.3 Causes Granulocytes From Patients with Chronic Granulocytic Leukemia to Differentiate Into Monocyte-Macrophages, Exp. Hematol. 11 (Suppl. 14):200, 1983 (abstract enclosed).
Olsson et al. Induction of Differentiation of the Human Histocytic Lymphoma Cell Line U-937 by 1a,25-Dihydroxycholecalciferol, Cancer Research 43 (12), 5862-5867, 1983.
Eisman et al., 1,25-Dihydroxyvitamin D Receptor in Breast Cancer Cells, Lancet, Dec. 22/29: 1335-1336, 1979.
Frampton et al., Presence of 1,25-Dihydroxyvitamin D.sub.3 Receptors in Established Human Cancer Cell Lines in Culture, Cancer Research 42:1116-1119, 1982.
Colston, et al., 1,25-Dihydroxyvitamin D.sub.3 Receptors in Human Epithelial Cancer Research 42:856-859, 1982.
Sher et al., Whole Cell Uptake and Nuclear Localization of 1,25-Dihydroxycholoecalciferol by Breast Cancer Cells in Culture, Biochem J. 200:315-320, 1981.
Frampton et al., Inhibition of Human Cancer Cell Growth by 1,25-Dihydroxyvitamin D.sub.3 Metabolites, Cancer Research 43:4443-4447, 1983.
Honma et al., 1a,25-Dihydroxyvitamin D.sub.3 and 1a-hydroxyvitamin D.sub.3 Prolong Survival Time of Mice Inoculated with Myeloid Leukemia Cells, Cell Biology, 80:201-204; 1983.
Sato et al., Antitumor Effect of 1a-hydroxyvitamin D.sub.3 Tohoku, J. Exp. Med., 138 445-446, 1982.
McCarthy et al., A Role of 1,25-Dihydroxyvitamin D.sub.3 in Control of Bone Marrow Collagen Deposition? Lancet, Jan. 14, 78-80, 1984.
Kasukabe et al. Control of Proliferating Potential of Myeloid Leukemia Cells During Long Term Treatment with Vitamin D.sub.3 Analogues and Other Differentiation Inducers in Combination with AntiLeukemic Drugs, Cancer Res. 47(6):567-572, 1987.
Eisman et al., Suppression of In Vivo Growth of Human Cancer Solid Tumor Xenografts, by 1,25-Dihydroxyvitamin D.sub.3, Cancer Research 47:21-25, 1987.
Malloy et al., p. 475, The Journal of Investigative Dermatology, Mar. 1989, vol. 92, No. 3.
Reitsma et al., Vitamin D.sub.3 Regulates C-myc Oncogene Expression in HL-60 Leukemic Cells, J. Cell. Biol. 97(5):347a, 1983.
Janistyn, "Handbuch der Kosmetika and Riechstoffe".
K. Schaefer, D. Von Herrath "Vitamin D 1980-Eine Bestandsaufnahme" Klin Wochenschr 59:525-534, 1981.
Dokoh, et al., The Ovary: A Target Organ for 1,25-Dihydroxyvitamin D.sub.3, Endocrinology 112:200-206, 1983.
Murao et al., Control of Macrophage Cell Differentiation in Human Promvelocytic HL-60 Leukemia Cells by 1,25-Dihydroxyvitamin D.sub.3 and Phorbol-12-myristate-13-acetate, Cancer Research 43(8):4989-4996, 1983.
Baggiolini, deceased Enrico G.
Hennessy Bernard M.
Shiuey Shian-Jan
Truitt Gary A.
Uskokovic Milan R.
Ciambrone Coletti Ellen
Criares T. J.
Gould George M.
Hoffmann-La Roche Inc.
Johnston George W.
LandOfFree
Vitamin D3 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D3 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D3 analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-134437